Product Code: TMRGL414
TMR's report on the global clinical laboratory services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global clinical laboratory services market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical laboratory services market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical laboratory services market.
The report delves into the competitive landscape of the global clinical laboratory services market. Key players operating in the global clinical laboratory services market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global clinical laboratory services market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Clinical Laboratory Services Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Clinical Laboratory Services Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Key Mergers & Acquisitions
- 5.3. Healthcare Industry Overview
- 5.4. Covid19 Impact Analysis
6. Global Clinical Laboratory Services Market Analysis and Forecast, by Test Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Test Type, 2017-2031
- 6.3.1. Clinical Chemistry
- 6.3.2. Medical Microbiology & Cytology
- 6.3.3. Food Intolerance Test
- 6.3.4. Human & Tumor Genetics
- 6.3.5. Other Esoteric Tests
- 6.4. Market Attractiveness Analysis, by Test Type
7. Global Clinical Laboratory Services Market Analysis and Forecast, by Service Provider
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Service Provider, 2017-2031
- 7.3.1. Stand-alone Laboratories
- 7.3.2. Hospital-based Laboratories
- 7.3.3. Contract Research Organizations (CROs)
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by Service Provider
8. Global Clinical Laboratory Services Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Clinical Laboratory Services Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value Forecast, by Test Type, 2017-2031
- 9.2.1. Clinical Chemistry
- 9.2.2. Medical Microbiology & Cytology
- 9.2.3. Food Intolerance Test
- 9.2.4. Human & Tumor Genetics
- 9.2.5. Other Esoteric Tests
- 9.3. Market Value Forecast, by Service Provider, 2017-2031
- 9.3.1. Stand-alone Laboratories
- 9.3.2. Hospital-based Laboratories
- 9.3.3. Contract Research Organizations (CROs)
- 9.3.4. Others
- 9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Test Type
- 9.5.2. By Service Provider
- 9.5.3. By Country
10. Europe Clinical Laboratory Services Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Test Type, 2017-2031
- 10.2.1. Clinical Chemistry
- 10.2.2. Medical Microbiology & Cytology
- 10.2.3. Food Intolerance Test
- 10.2.4. Human & Tumor Genetics
- 10.2.5. Other Esoteric Tests
- 10.3. Market Value Forecast, by Service Provider, 2017-2031
- 10.3.1. Stand-alone Laboratories
- 10.3.2. Hospital-based Laboratories
- 10.3.3. Contract Research Organizations (CROs)
- 10.3.4. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Test Type
- 10.5.2. By Service Provider
- 10.5.3. By Country/Sub-region
11. Asia Pacific Clinical Laboratory Services Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Test Type, 2017-2031
- 11.2.1. Clinical Chemistry
- 11.2.2. Medical Microbiology & Cytology
- 11.2.3. Food Intolerance Test
- 11.2.4. Human & Tumor Genetics
- 11.2.5. Other Esoteric Tests
- 11.3. Market Value Forecast, by Service Provider, 2017-2031
- 11.3.1. Stand-alone Laboratories
- 11.3.2. Hospital-based Laboratories
- 11.3.3. Contract Research Organizations (CROs)
- 11.3.4. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Test Type
- 11.5.2. By Service Provider
- 11.5.3. By Country/Sub-region
12. Latin America Clinical Laboratory Services Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Test Type, 2017-2031
- 12.2.1. Clinical Chemistry
- 12.2.2. Medical Microbiology & Cytology
- 12.2.3. Food Intolerance Test
- 12.2.4. Human & Tumor Genetics
- 12.2.5. Other Esoteric Tests
- 12.3. Market Value Forecast, by Service Provider, 2017-2031
- 12.3.1. Stand-alone Laboratories
- 12.3.2. Hospital-based Laboratories
- 12.3.3. Contract Research Organizations (CROs)
- 12.3.4. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Test Type
- 12.5.2. By Service Provider
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Clinical Laboratory Services Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Test Type, 2017-2031
- 13.2.1. Clinical Chemistry
- 13.2.2. Medical Microbiology & Cytology
- 13.2.3. Food Intolerance Test
- 13.2.4. Human & Tumor Genetics
- 13.2.5. Other Esoteric Tests
- 13.3. Market Value Forecast, by Service Provider, 2017-2031
- 13.3.1. Stand-alone Laboratories
- 13.3.2. Hospital-based Laboratories
- 13.3.3. Contract Research Organizations (CROs)
- 13.3.4. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Test Type
- 13.5.2. By Service Provider
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 14.2. Market Share Analysis, by Company (2021)
- 14.3. Company Profiles
- 14.3.1. Charles River Laboratories International, Inc.
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Financial Analysis
- 14.3.1.3. Growth Strategies
- 14.3.1.4. SWOT Analysis
- 14.3.2. SYNLAB International GmbH
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Financial Analysis
- 14.3.2.3. Growth Strategies
- 14.3.2.4. SWOT Analysis
- 14.3.3. Sonic Healthcare
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Financial Analysis
- 14.3.3.3. Growth Strategies
- 14.3.3.4. SWOT Analysis
- 14.3.4. NeoGenomics Laboratories, Inc.
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Financial Analysis
- 14.3.4.3. Growth Strategies
- 14.3.4.4. SWOT Analysis
- 14.3.5. Genomic Health, Inc.
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Financial Analysis
- 14.3.5.3. Growth Strategies
- 14.3.5.4. SWOT Analysis
- 14.3.6. Fresenius Medical Care AG & Co. KGaA
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Financial Analysis
- 14.3.6.3. Growth Strategies
- 14.3.6.4. SWOT Analysis
- 14.3.7. Laboratory Corporation of America Holdings
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Financial Analysis
- 14.3.7.3. Growth Strategies
- 14.3.7.4. SWOT Analysis
- 14.3.8. Unilabs
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Financial Analysis
- 14.3.8.3. Growth Strategies
- 14.3.8.4. SWOT Analysis
- 14.3.9. Quest Diagnostics Incorporated
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Financial Analysis
- 14.3.9.3. Growth Strategies
- 14.3.9.4. SWOT Analysis
- 14.3.10. Eurofins Scientific SE
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Financial Analysis
- 14.3.10.3. Growth Strategies
- 14.3.10.4. SWOT Analysis